{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:40:14Z","timestamp":1756438814641,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,28]]},"DOI":"10.7759\/cureus.91205","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:59:03Z","timestamp":1756436343000},"source":"Crossref","is-referenced-by-count":0,"title":["Dual Thrombophilic Mutations in Cerebral Venous Sinus Thrombosis: A Case Report Emphasizing Thrombophilia Screening and Indefinite Anticoagulation"],"prefix":"10.7759","author":[{"given":"Yu","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105145","article-title":"Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and\u00a0 literature review","volume":"29","author":"Alet M","year":"2020","unstructured":"Alet M, Ciardi C, Alem\u00e1n A, et al.. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and\u00a0 literature review. J Stroke Cerebrovasc Dis. 2020, 29:105145. 10.1016\/j.jstrokecerebrovasdis.2020.105145","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik G","year":"2024","unstructured":"Saposnik G, Bushnell C, Coutinho JM, et al.. Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. Stroke. 2024, 55:e77-90. 10.1161\/STR.0000000000000456","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.03.021","article-title":"Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis","volume":"272","author":"Nagaraja D","year":"2008","unstructured":"Nagaraja D, Noone ML, Bharatkumar VP, Christopher R. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis. J Neurol Sci. 2008, 272:43-7. 10.1016\/j.jns.2008.03.021","journal-title":"J Neurol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2007.01.002","article-title":"Hyperhomocysteinemia and venous thrombosis","volume":"44","author":"Gatt A","year":"2007","unstructured":"Gatt A, Makris M. Hyperhomocysteinemia and venous thrombosis. Semin Hematol. 2007, 44:70-6. 10.1053\/j.seminhematol.2007.01.002","journal-title":"Semin Hematol"},{"key":"ref5","article-title":"The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk","volume":"9","author":"Levine AJ","year":"2000","unstructured":"Levine AJ, Siegmund KD, Ervin CM, Diep A, Lee ER, Frankl HD, Haile RW. The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2000, 9:657-63.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cga.12232","article-title":"Genetic polymorphisms and folate status","volume":"57","author":"Hiraoka M","year":"2017","unstructured":"Hiraoka M, Kagawa Y. Genetic polymorphisms and folate status. Congenit Anom (Kyoto). 2017, 57:142-9. 10.1111\/cga.12232","journal-title":"Congenit Anom (Kyoto)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2125_18","article-title":"A study of hyperhomocysteinemia in cerebral venous sinus thrombosis","volume":"152","author":"Kalita J","year":"2020","unstructured":"Kalita J, Singh VK, Misra UK. A study of hyperhomocysteinemia in cerebral venous sinus thrombosis. Indian J Med Res. 2020, 152:584-94. 10.4103\/ijmr.IJMR_2125_18","journal-title":"Indian J Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1076029612466285","article-title":"Hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T polymorphism in cerebral veno-sinus thrombosis","volume":"20","author":"Bharatkumar VP","year":"2014","unstructured":"Bharatkumar VP, Nagaraja D, Christopher R. Hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T polymorphism in cerebral veno-sinus thrombosis. Clin Appl Thromb Hemost. 2014, 20:78-83. 10.1177\/1076029612466285","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.09.005","article-title":"The effect of the plasminogen activator inhibitor-1 4G\/5G polymorphism on the thrombotic risk","volume":"122","author":"Tsantes AE","year":"2008","unstructured":"Tsantes AE, Nikolopoulos GK, Bagos PG, Bonovas S, Kopterides P, Vaiopoulos G. The effect of the plasminogen activator inhibitor-1 4G\/5G polymorphism on the thrombotic risk. Thromb Res. 2008, 122:736-42. 10.1016\/j.thromres.2007.09.005","journal-title":"Thromb Res"},{"key":"ref10","article-title":"Plasminogen activator inhibitor-1 4G\/5G polymorphism is associated with coronary artery disease risk: a meta-analysis","volume":"7","author":"Zhang H","year":"2014","unstructured":"Zhang H, Dong P, Yang X, Liu Z. Plasminogen activator inhibitor-1 4G\/5G polymorphism is associated with coronary artery disease risk: a meta-analysis. Int J Clin Exp Med. 2014, 7:3777-88.","journal-title":"Int J Clin Exp Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13381","article-title":"European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology","volume":"24","author":"Ferro JM","year":"2017","unstructured":"Ferro JM, Bousser MG, Canh\u00e3o P, et al.. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017, 24:1203-13. 10.1111\/ene.13381","journal-title":"Eur J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.025","article-title":"Endovascular thrombolysis or thrombectomy for cerebral venous thrombosis: study of nationwide inpatient sample 2004-2014","volume":"28","author":"Siddiqui FM","year":"2019","unstructured":"Siddiqui FM, Weber MW, Dandapat S, et al.. Endovascular thrombolysis or thrombectomy for cerebral venous thrombosis: study of nationwide inpatient sample 2004-2014. J Stroke Cerebrovasc Dis. 2019, 28:1440-7. 10.1016\/j.jstrokecerebrovasdis.2019.03.025","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.1928","article-title":"Antithrombotic therapy for venous thromboembolic disease","volume":"317","author":"Jain A","year":"2017","unstructured":"Jain A, Cifu AS. Antithrombotic therapy for venous thromboembolic disease. JAMA. 2017, 317:2008-9. 10.1001\/jama.2017.1928","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.037541","article-title":"Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study","volume":"53","author":"Yaghi S","year":"2022","unstructured":"Yaghi S, Shu L, Bakradze E, et al.. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022, 53:728-38. 10.1161\/STROKEAHA.121.037541","journal-title":"Stroke"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398256-dual-thrombophilic-mutations-in-cerebral-venous-sinus-thrombosis-a-case-report-emphasizing-thrombophilia-screening-and-indefinite-anticoagulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:59:05Z","timestamp":1756436345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398256-dual-thrombophilic-mutations-in-cerebral-venous-sinus-thrombosis-a-case-report-emphasizing-thrombophilia-screening-and-indefinite-anticoagulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.91205","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}